Stockholders' Equity and Earnings per Share (Tables)

12 Months Ended

Dec. 31, 2023

The following dividends were declared in 2023, 2022 and 2021 under NXP’s quarterly dividend program which was introduced as of the third quarter of 2018:


	2023	2022	2021
Dividends declared (in millions)	1,048	885	606
Dividends declared (per share)	4.056	3.38	2.25

Schedule of Transactions from Employee Option and Share Plans

The following transactions took place resulting from employee option and share plans:


	2023	2022	2021
Total shares in treasury at beginning of year	15,056,232	9,569,359	9,044,952
Total cost	2,799	1,932	1,037
Shares acquired under repurchase program	5,460,135	8,330,021	20,628,901
Average price in $ per share	192.16	171.59	194.63
Total cost of repurchases	1,049	1,429	4,015
Shares delivered	3,186,782	2,843,148	5,104,494
Average price in $ per share	200.38	197.83	102.88
Amount received	71	59	62
Shares retired	—	—	15,000,000
Total shares in treasury at end of year	17,329,585	15,056,232	9,569,359
Total cost	3,210	2,799	1,932

Computation of Earnings per Share (EPS)

The computation of earnings per share (EPS) is presented in the following table:


	2023	2022	2021
Net income (loss)	2,822	2,833	1,906
Less: Net income (loss) attributable to non-controlling interests	25	46	35
Net income (loss) attributable to stockholders	2,797	2,787	1,871

Weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands)	258,381	261,879	270,687
Plus incremental shares from assumed conversion of:
Options 1)	188	276	386
Restricted Share Units, Performance Share Units and Equity Rights 2)	2,801	1,898	4,573
Dilutive potential common share	2,989	2,174	4,959
Adjusted weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands) 1)	261,370	264,053	275,646

EPS attributable to stockholders in $:
Basic net income (loss)	10.83	10.64	6.91
Diluted net income (loss)	10.70	10.55	6.79

1)No stock options to purchase shares of NXP’s common stock that were outstanding in 2023 (2022: none; 2021: none) were anti-dilutive and were not included in the computation of diluted EPS because the exercise price was greater than the average fair market value of the common stock or the number of shares assumed to be repurchased using the proceeds of unrecognized compensation expense and exercise prices was greater than the weighted average number of shares underlying outstanding stock options.

2)No unvested RSU’s, PSU’s and equity rights that were outstanding in 2023 (2022: 0.3 shares; 2021: 0.1 million shares) were anti-dilutive and were not included in the computation of diluted EPS because the number of shares assumed to be repurchased using the proceeds of unrecognized compensation expense was greater than the weighted average number of outstanding unvested RSU’s, PSU’s and equity rights or the performance goal has not been met.